سعر الموتريب فورت Almotrip forte‏ 12.5 مجم 2 قرص 2026

Almotriptan 12.5 mg film-coated tablets (triptan) for acute migraine; Egyptian product of European Egyptian Pharm. Ind.

• Most common at the therapeutic dose: dizziness, somnolence, nausea, vomiting and fatigue (none above 1.5%).International label, same formulation · electronic medicines compendium (emc), UK
• In adult trials: nausea, dry mouth and paresthesia (about 1-2%); rare serious cardiac reactions.International label, same formulation · DailyMed (U.S. National Library of Medicine)

• Hypersensitivity; ischaemic heart disease (MI, angina, silent ischaemia, Prinzmetal's angina); severe or uncontrolled hypertension; previous stroke/TIA; peripheral vascular disease; concomitant ergotamine/derivatives or other 5-HT1B/1D agonists; severe hepatic impairment.International label, same formulation · electronic medicines compendium (emc), UK
• Ischaemic heart disease or coronary vasospasm; cerebrovascular syndromes; peripheral vascular disease including ischaemic bowel disease; uncontrolled hypertension; use within 24 h of ergot-type drugs or another triptan; hemiplegic or basilar migraine; hypersensitivity.International label, same formulation · DailyMed (U.S. National Library of Medicine)

• Serious cardiac events including myocardial infarction and coronary vasospasm have been reported; evaluate cardiovascular risk before use.International label, same formulation · DailyMed (U.S. National Library of Medicine)
• Serotonin syndrome may occur, particularly with SSRIs or SNRIs.International label, same formulation · DailyMed (U.S. National Library of Medicine)
• Overuse of acute migraine drugs (10 or more days per month) may cause medication overuse headache.International label, same formulation · DailyMed (U.S. National Library of Medicine)

• Ergotamine-containing or ergot-type medicationsDo not use within 24 hours of each other.DailyMed (U.S. National Library of Medicine)
• Other 5-HT1 agonists (triptans)Do not use within 24 hours of each other.DailyMed (U.S. National Library of Medicine)
• SSRIs / SNRIsLife-threatening serotonin syndrome reported with combined use of triptans and SSRIs/SNRIs.DailyMed (U.S. National Library of Medicine)

• Very limited data in pregnancy; animal studies do not indicate harmful effects; caution when prescribing to pregnant women.International label, same formulation · electronic medicines compendium (emc), UK
• Developmental toxicity in animals at doses above clinical exposure; no adequate studies in pregnant women; use only if benefit justifies risk.International label, same formulation · DailyMed (U.S. National Library of Medicine)
• No data on excretion in human milk (excreted in rat milk); use with caution; infant exposure may be minimised by avoiding breastfeeding for 24 hours after treatment.International label, same formulation · electronic medicines compendium (emc), UK

• Almotriptan: Selective 5-HT1B and 5-HT1D receptor agonist; these receptors mediate vasoconstriction of certain cranial vessels (UK SmPC section 5.1).